Navigation Links
LCA-Vision Announces Upcoming Investment Community Events
Date:1/28/2008

Releasing Fourth Quarter & Full-Year 2007 Financial Results on Monday,

February 11, 2008 Presenting at the UBS Global Healthcare Services Conference on Tuesday,

February 12, 2008

CINCINNATI, Jan. 28 /PRNewswire-FirstCall/ -- LCA-Vision Inc. (Nasdaq: LCAV), a leading provider of laser vision correction services under the LasikPlus brand, announced today upcoming investment community events.

Fourth Quarter & Full-Year 2007 Financial Results

LCA-Vision will release fourth quarter and full-year 2007 financial results prior to market opening on Monday, February 11, 2008. A conference call and webcast to discuss the results will also be held on Monday, February 11, 2008 at 10:00 a.m. (ET). To access the conference call, dial 866-322-1352 (within the United States and Canada), or 706-758-1564 (international callers). The webcast will be available at the investor relations section of LCA-Vision's website. A replay of the call and webcast will begin approximately two hours after the live call has ended. To access the replay, dial 800-642-1687 (within the United States and Canada), or 706-645-9291 (international callers) and enter the conference ID number: 297 23 746.

UBS Global Healthcare Services Conference

Members of LCA-Vision's executive management team will present at the UBS Global Healthcare Services Conference on Tuesday, February 12, 2008 at 2:30 p.m. ET at the Grand Hyatt Hotel in New York. A webcast of the event will be available at the Investor Relations section of LCA-Vision's website.

About LCA-Vision Inc./LasikPlus

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus brand, operates 73 LasikPlus fixed-site laser vision correction centers in 32 states and 57 markets in the United States and a joint venture in Canada. Additional company information is available at '/>"/>

SOURCE LCA-Vision Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against LCA-Vision Inc.
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...exas Health Science Center at Houston will launch ...s (TEXAS), to promote geriatrics training for phys... the Donald W. Reynolds Foundation and $1.25 milli...ch geriatric medicine principles to everyone from ...icians. With the reach of Lyndon B. Johnson Genera...
(Date:11/21/2008)...ll/ -- The Providence Service,Corporation (Nasdaq...he Company,s,Chief Operating Officer, has been ap... Norris, appointment fills the vacancy left by the... returns the board to six members. Mr.,Norris wi... Mr. Norris, age 41, has been with Providence si...
(Date:11/21/2008)...nst Lennox-Gastaut syndrome , , FRIDAY, ...el (rufinamide) has been approved as a supplementa...Lennox-Gastaut syndrome, the U.S. Food and Drug Ad...as based on results of a four-month clinical trial...patients who took a placebo, those who took the dr...
(Date:11/21/2008)...ewswire/ -- New research at West Virginia Univers...bacco product aimed at young adults is catching on... Camel Snus - touted as a socially acceptable way ...levels of nicotine. , , "Camel Snus contain...aid Bruce Adkins of the state Division of Tobacco ...
Breaking Medicine News(10 mins):Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:FDA Approves New Drug for Severe Epilepsy 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3
...e ‘Mini’ Way to Stop Atrial Fibrillation in its Tr...ds of Americans with intermittent atrial fibrillat... of the Cox-Maze procedure //that involves scarrin...es sent by the brain to travel correctly. Richard ...
...bert Watson, a graduate student in the Section of ...f Medicine has found the uncommon path taken by Ca...s cells. Records show that, "campylobacteriosis,"...rhea worldwide, strikes 2.4 million Americans a ye...
...ala Lumpur: Five Malaysian states have registered ...first week of the year, with authorities fearing t...ead due to the rainy season, reports said Wednesda...an registered the highest jump, from 18 cases in t...
...new study finds that obesity increases the risk of...ot increase the overall risk a man will be diagnos... CANCER, a peer-reviewed journal of the American C... higher body mass index (BMI) and weight gain in a...
Other Medicine News:Health News:The Uncommon Pathway of Campylobacter Jejuni 2Health News:Mosquito-borne Dengue Disease on the Rise in Five Malaysian States 2Health News:Excess Weight and Adult Weight Gain Increase Risk of Prostate Cancer Death 2
(Date:11/20/2008)...E RESULTS OF FIRST PHASE III TRIAL SHOW SIGNIFICAN...MENT IN DAILY FUNCTION, IN, ...f., and BRUSSELS, Belgium, Nov. 20 /PRNewswire-Fir...JAZZ ) and UCB (Euronext Brussels: UCB),announced...the first of two,Phase III pivotal clinical trial...
(Date:11/20/2008).... 20 Bionovo, Inc.,(Nas...esults from the Phase 1B,clinical trial of their ...,cancer, BZL101, at the Society for Integrative O...ta, Georgia. The Company,s oral presentation was ...esented as a part of the Best of the,SIO Session ...
(Date:11/20/2008)...wswire/ -- Clinical data from a prospective,regis...ymposium shows DVT,treatment with the Trellis(R) ... Inc. (Santa Clara, CA) successfully breaks up the... , This technique, called isolated pharmaco... quickly and safely than current catheter-directed...
(Date:11/19/2008)... Posit Science Corporation,researc... for Neuroscience,Annual Conference in Washington... may benefit Baby Boomers. The computerized brain... adaptive exercises that target auditory and,lang... generalized,improvements in cognition by improvi...
Breaking Medicine Technology:Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Brookdale to Present at Citi Small 26 Mid Cap Conference on March 17 13982 1GeneNews receives ISO 13485 accreditation 3846 1GeneNews receives ISO 13485 accreditation 3846 2Mentice AB Announces Leadership Changes Within Its Worldwide Operations 3844 1Mentice AB Announces Leadership Changes Within Its Worldwide Operations 3844 2Peregrine Pharmaceuticals Announces Positive Data From Cotara 28R 29 Brain Cancer Trials 13980 1Peregrine Pharmaceuticals Announces Positive Data From Cotara 28R 29 Brain Cancer Trials 13980 2Peregrine Pharmaceuticals Announces Positive Data From Cotara 28R 29 Brain Cancer Trials 13980 3Peregrine Pharmaceuticals Announces Positive Data From Cotara 28R 29 Brain Cancer Trials 13980 4Peregrine Pharmaceuticals Announces Positive Data From Cotara 28R 29 Brain Cancer Trials 13980 5Peregrine Pharmaceuticals Announces Positive Data From Cotara 28R 29 Brain Cancer Trials 13980 6
...s from placebo,controlled phase IIa study in patie...IEREN (Zurich), Switzerland, May 15, 2007 - Cytos ...e results from a multi-centre,and placebo-controll...CYT003-QbG10, an immunotherapeutic product candida...dy included 40 patients,suffering from mild to mod...
...Weeks Reinforces,Benefits of Using REVLIMID with L...if., May 15, 2007 /PRNewswire/ -- The,Internationa...nd,providing education, advocacy and support for m...ans - today said that for the,second time in four ...R) has demonstrated positive findings and therefor...
Other Medicine Technology:Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 2Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 3Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 4Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 5Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 6Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 7The International Myeloma Foundation Reports Positive Shift In,Treatment Paradigm For Patients 2The International Myeloma Foundation Reports Positive Shift In,Treatment Paradigm For Patients 3
Kaye Skin Hook, Single Prong
Designated most popular model or size.
Large deep curve.
Needle tip electrode, davol advantage electrosurgical attachments, 33cm (with extendible outer sheath), non-sterile. These products are supplied non-sterile and must be sterilized before use. Reusabl
Medicine Products: